ArticleClinical drug investigation2023
Efficacy and Safety of Switching from Sitagliptin to Ipragliflozin in Obese Japanese Patients with Type 2 Diabetes Mellitus: A Single-Arm Multicenter Interventional Study.
Kentaro Watanabe et al.PubMed ↗Publisher ↗
No numbers read from the abstract.